BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shruti Vishal Rao & PACs BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narsimha Shibroor Kamath BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shruti Vishal Rao BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shruti Vishal Rao BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Vibha Gagan Sharma BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Vibha Gagan Sharma BLISS GVS PHARMA LTD. - 506197 - Disclosure Of Inter-Se Transfer Of Shares Between Promoters/Promoter Group In Accordance With Regulation 10(5) Of SEBI (SAST) Regulations, 2011
Pursuant of the Regulation 3 of SEBI (Prohibition of Insider Trading) Regulations 2015 and in compliance with Regulation 10(5) of SEBI (SAST) Regulations, 2011, we would like to inform your good office that acquirers as mentioned below, being a part of Promoters/ Promoter Group of Bliss GVS Pharma Limited (hereinafter referred as 'the Company") intends to acquire 30,00,000 (Thirty Lakh) Equity Shares of the Company by way of inter-se transfer on or after March 28, 2022, in terms of Regulation 10(1)(a) (i) & (ii) of SEBI (SAST) Regulations, 2011 by way of execution of Gift Deed amongst Promoter & Promoter Group. BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shruti Vishal Rao & Dr Vibha Sharma BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shruti V Rao & Dr. Vibha G Sharma BLISS GVS PHARMA LTD. - 506197 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for FMR LLC & FIL Ltd